Get the latest market trends in your inbox

Stay on top of the latest market trends and economic insights with the Axios Markets newsletter. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Denver news in your inbox

Catch up on the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Des Moines news in your inbox

Catch up on the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Minneapolis-St. Paul news in your inbox

Catch up on the most important stories affecting your hometown with Axios Minneapolis-St. Paul

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tampa-St. Petersburg news in your inbox

Catch up on the most important stories affecting your hometown with Axios Tampa-St. Petersburg

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

A Port Authority police officer stands watch at Newark Liberty International Airport. Photo: Eduardo Munoz Alvarez/Getty Images

Beginning next week, the U.S. will no longer require travelers arriving from certain countries to be funneled through 15 major airports to undergo enhanced coronavirus screenings, the Centers for Disease Control and Prevention (CDC) said Thursday.

What they're saying: The CDC said in a statement that it is removing the requirements on Monday due to a better understanding that "symptom-based screening has limited effectiveness because people with COVID-19 may have no symptoms or fever at the time of screening, or only mild symptoms."

  • "Transmission of the virus may occur from passengers who have no symptoms or who have not yet developed symptoms of infection. Therefore, CDC is shifting its strategy and prioritizing other public health measures to reduce the risk of travel-related disease transmission," the CDC said.
  • "[R]esources will instead be dedicated to more effective mitigation efforts that focus on the individual passenger, including: pre-departure, in-flight, and post-arrival health education for passengers; robust illness response at airports; voluntary collection of contact information from passengers ...; potential testing to reduce the risk of travel-related transmission of the virus that causes COVID-19 and movement of the virus from one location to another..."

Worth noting: The increased screening requirements, which began in January, applied to people arriving from China, Iran, most countries in continental Europe, the United Kingdom, Ireland and Brazil. Most non-U.S. citizens from those countries have been barred from entering the U.S.

Go deeper

Health expert: Black and Latino homelessness will spike without pandemic relief package

Photo: Axios

Black and Latino Americans are facing ā€œterrible financial problemsā€ due to COVID-19, health expert Robert Blendon said on Tuesday at a virtual Axios event.

Why it matters: The pandemic has hit communities of color harder than white Americans, and the population of homeless Black Americans and Latinos will only increase if there is no emergency federal aid, Brendon said.

UPS and Ford prepare for vaccine distribution with ultra-cold freezers

Photo: Jeff Kowalsky/AFP via Getty

UPS and Ford Motor Company have both announced they ordered portable, ultra-low temperature freezers for storing coronavirus vaccines when they become available.

Why it matters: While the promising vaccine developed by Pfizer and BioNTech is 95% effective, it can only be stored at or around -70 degrees Celsius.